[3H]ditolylguanidine binding to human brain sigma sites is diminished after haloperidol treatment.
Reynolds
G P
GP
Department of Biomedical Science, University of Sheffield, U.K.
Brown
J E
JE
Middlemiss
D N
DN
D001665:Binding Sites; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D006146:Guanidines / Q000378:metabolism*; D006220:Haloperidol / Q000494:pharmacology*; D006801:Humans; D012559:Schizophrenia / Q000378:metabolism; D014316:Tritium
D006146:Guanidines; D014316:Tritium; D006220:Haloperidol; C050232:1,3-ditolylguanidine